Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · CareCloud, Inc. (CCLD)

CareCloud Q2 revenue rises 16% to $31.9 million, but net income falls to $1.1 million

Mixed Impact 3 of 5 earnings Written later

CareCloud reported second quarter 2026 revenue of $31.9 million, up from $27.4 million a year earlier, but GAAP net income fell to $1.1 million from $2.9 million and GAAP EPS was $0.00 versus $0.04. The company reaffirmed its full-year 2026 guidance, and management attributed the lower profit to higher R&D spending and higher interest expense after the Series B preferred stock redemption.

Key points

  • Q2 2026 revenue of $31.9 million vs. $27.4 million in Q2 2025; adjusted EBITDA of $5.9 million vs. $6.5 million.
  • GAAP net income of $1.1 million vs. $2.9 million; GAAP EPS of $0.00 vs. $0.04 per share.
  • Full-year 2026 guidance reaffirmed: revenue $128 million to $132 million, adjusted EBITDA $29 million to $31 million, GAAP EPS $0.20 to $0.23.
  • Series B Preferred Stock fully redeemed on May 15, 2026; the company acquired Empower Healthcare & Compliance Partners.

The filing

CompanyCareCloud, Inc. (CCLD)
Form8-K, current report
Filed with the SECAug 6, 2026, 7:10 AM ET
Accession number0001493152-26-036255

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.